KRAS and cancer: The targeted sequencing of other cancer-related genes, including KRAS [24], BRAF [24, 25], CDKN1A [26], KIT [27] (abstract only), JAK2, FOXL2, IDH1, AKT1 and EZH2 [25] did not reveal any pathogenic mutations.